Joachim F. Wernicke
Chief Tech/Sci/R&D Officer bei REPROS THERAPEUTICS INC
Profil
Joachim F.
Wernicke is currently the Chief Medical Officer at Repros Therapeutics, Inc. He previously worked as the Vice President-Clinical & Regulatory Affairs at LivaNova USA, Inc. and as an Advisor at MediGen Group LLC.
He holds a doctorate degree from the University of California, Los Angeles and another doctorate degree from the University of California, Irvine.
Aktive Positionen von Joachim F. Wernicke
| Unternehmen | Position | Beginn |
|---|---|---|
| REPROS THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 05.02.2013 |
Ehemalige bekannte Positionen von Joachim F. Wernicke
| Unternehmen | Position | Ende |
|---|---|---|
| CYBERONICS, INC. | General Counsel | - |
MediGen Group LLC
 MediGen Group LLC Investment ManagersFinance Founded in 2001 by Ronald Zimmerman, MediGen Group LLC is a venture capital firm located in Houston, Texas | Private Equity Investor | - |
Ausbildung von Joachim F. Wernicke
| University of California, Los Angeles | Doctorate Degree |
| University of California, Irvine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
LivaNova USA, Inc.
 LivaNova USA, Inc. Medical SpecialtiesHealth Technology LivaNova USA, Inc. engages in the design, development, sales, and marketing of implantable medical devices. It operates through providing neuromodulation therapy, vagus nerve stimulation therapy (VNS Therapy) for the treatment of refractory epilepsy, and treatment-resistant depression (TRD). The company was founded in 1987 and is headquartered in Granbury, TX. | Health Technology |
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
MediGen Group LLC
MediGen Group LLC Investment ManagersFinance Founded in 2001 by Ronald Zimmerman, MediGen Group LLC is a venture capital firm located in Houston, Texas | Finance |
